108 related articles for article (PubMed ID: 8604621)
1. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.
Smith AJ; Holt RE; Fitzpatrick JB; Palacios IF; Gold HK; Werner W; Bovill EG; Fuster V; Jang IK
Am Heart J; 1996 Mar; 131(3):434-9. PubMed ID: 8604621
[TBL] [Abstract][Full Text] [Related]
2. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: potential mechanisms for heightened prothrombotic potential.
Becker RC; Spencer FA; Li Y; Ball SP; Ma Y; Hurley T; Hebert J
J Am Coll Cardiol; 1999 Oct; 34(4):1020-7. PubMed ID: 10520784
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Lauer MA; Houghtaling PL; Peterson JG; Granger CB; Bhatt DL; Sapp SK; Simoons ML; Harrington RA; Topol EJ; Lincoff AM;
Circulation; 2001 Dec; 104(23):2772-7. PubMed ID: 11733393
[TBL] [Abstract][Full Text] [Related]
8. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
[TBL] [Abstract][Full Text] [Related]
9. Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.
Ziakas A; Gavrilidis S; Makris P; Louridas G
J Interv Cardiol; 2005 Apr; 18(2):139-44. PubMed ID: 15882162
[TBL] [Abstract][Full Text] [Related]
10. Role of prolonged intravenous heparin in unstable angina patients prior to coronary angioplasty.
Gangasani SR; O'Neill WW; Grines CL
J Interv Cardiol; 2001 Aug; 14(4):423-8. PubMed ID: 12053496
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
[TBL] [Abstract][Full Text] [Related]
12. Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.
Oldgren J; Linder R; Grip L; Siegbahn A; Wallentin L
Eur Heart J; 1999 Nov; 20(22):1657-66. PubMed ID: 10543929
[TBL] [Abstract][Full Text] [Related]
13. Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators.
Bittl JA
Am Heart J; 1995 Sep; 130(3 Pt 2):658-65. PubMed ID: 7668214
[TBL] [Abstract][Full Text] [Related]
14. A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group.
Eur Heart J; 1997 Sep; 18(9):1416-25. PubMed ID: 9458447
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina.
Klootwijk P; Lenderink T; Meij S; Boersma H; Melkert R; Umans VA; Stibbe J; Müller EJ; Poortermans KJ; Deckers JW; Simoons ML
Eur Heart J; 1999 Aug; 20(15):1101-11. PubMed ID: 10413640
[TBL] [Abstract][Full Text] [Related]
16. Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty.
Gurbel PA; Navetta FI; Bates ER; Muller DW; Tenaglia AN; Miller MJ; Muhlstein B; Hermiller JB; Davidson CJ; Aguirre FV; Beauman GJ; Berdan LG; Leimberger JD; Bovill EG; Christenson RH; Ohman EM
Cathet Cardiovasc Diagn; 1996 Apr; 37(4):382-91. PubMed ID: 8721695
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of unstable angina after the discontinuation of heparin.
Théroux P; Waters D; Lam J; Juneau M; McCans J
N Engl J Med; 1992 Jul; 327(3):141-5. PubMed ID: 1608405
[TBL] [Abstract][Full Text] [Related]
18. Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes.
Mungall D; Lord M; Cason S; Treadwell P; Williams D; Tedrick D
Am J Cardiol; 1998 Sep; 82(5):574-9. PubMed ID: 9732882
[TBL] [Abstract][Full Text] [Related]
19. Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty.
Helft G; Choktron S; Beygui F; Le Feuvre C; Elalamy I; Metzger JP; Vacheron A; Samama MM
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):329-31. PubMed ID: 9829899
[TBL] [Abstract][Full Text] [Related]
20. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
